Bromocriptine Mesylate API

Name	Bromocriptine mesylate
Chinese name	甲磺酸溴隐亭
Cas Number	22260-51-1
Source	Europe
Qualifications	USDMF/CEP/-/-/-

Bromocriptine mesylate is a dopamine D2 receptor agonist developed by Novartis, Switzerland. It can stimulate the hypothalamus to release cortisol, growth hormone, prolactin and other hormones, and promote the body's biological clock to return to normal rhythm. Treat Parkinson's syndrome. After conducting follow-up studies on the pharmacological effects of bromocriptine mesylate, Ergo Science developed an oral immediate-release tablet of bromocriptine mesylate, which was first launched in the United States in November 2010. It can be used at the central nervous system level. It can control postprandial blood sugar by regulating brain neurobiochemical abnormalities and improve insulin resistance, thereby being used to treat type II diabetes. Studies have pointed out that the use of bromocriptine mesylate in the treatment of hyperprolactinemia, compared with α-dihydroergocriptine mesylate, can inhibit PRL synthesis and secretion, so that tumors shrink, lactation stops, and patients recover Normal ovulation cycle, while adverse reactions are significantly lower. In recent years, the domestic Parkinson’s disease drug market has continued to grow, reaching 2.3 billion yuan in 2016, with an average growth rate of 11.6% from 2013 to 2016. Bromocriptine mesylate is also ranked third in the Parkinson’s disease drug market The product.

Hot Tags: bromocriptine mesylate api, China, suppliers, manufacturers, factory, customized, price, pricelist, in stock, Lurasidone Hydrochloride API, Fondaparinux API, Troxagliptin Succinate API, Lercanidipine Hydrochloride API, Lapatinib Ditosylate API, Ulipristal Acetate API

• Previous: Calcium Acetate API
• Next: Remdesivir API